Identification of rare polymerase variants of hepatitis B virus using a two‐stage PCR with peptide nucleic acid clamping

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Medical Virology

• Publication date

  2004-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jmv.20026PMID 14981758
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudine.

  2008cited by this paper
• Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment.

  2002influential reference
• The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance.

  2001cited by this paper
• Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers.

  2001cited by this paper
• Rapid and Specific Genotyping System for Hepatitis B Virus Corresponding to Six Major Genotypes by PCR Using Type-Specific Primers

  2001cited by this paper
• Effect of hepatitis B virus mutants on efficacy of vaccination.

  2000cited by this paper
• Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

  2000cited by this paper
• Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance.

  2000influential reference
• A ONE-YEAR TRIAL OF LAMIVUDINE FOR CHRONIC HEPATITIS B

  2000cited by this paper
• Lamivudine as initial treatment for chronic hepatitis B in the United States.

  1999cited by this paper
• Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection.

  1999cited by this paper
• YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitrofull‐length viral DNA transfection

  1999cited by this paper
• Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy

  1999cited by this paper
• Detection of apolipoprotein B mRNA editing by peptide nucleic acid mediated PCR clamping.

  1999cited by this paper
• Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors.

  1999cited by this paper
• Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment.

  1998cited by this paper
• A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

  1998cited by this paper
• Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): Influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C

  1998cited by this paper
• Emergence and takeover of YMDD motif mutant hepatitis B virus during long‐term lamivudine therapy and re‐takeover by wild type after cessation of therapy

  1998influential reference
• Identification and characterization of mutations in hepatitis B virus resistant to lamivudine

  1998cited by this paper
• Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective

  1998cited by this paper
• Lamivudine resistance in immunocompetent chronic hepatitis B. Incidence and patterns.

  1997influential reference
• Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: A placebo‐controlled trial

  1997cited by this paper
• Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study.

  1997cited by this paper
• Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment

  1995cited by this paper
• Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes.

  1994cited by this paper
• PNA hybridizes to complementary oligonucleotides obeying the Watson–Crick hydrogen-bonding rules

  1993cited by this paper
• DNA unwinding upon strand-displacement binding of a thymine-substituted polyamide to double-stranded DNA.

  1993cited by this paper
• Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant.

  1992cited by this paper
• Mutations within the S Gene of Hepatitis B Virus Transmitted from Mothers to Babies Immunized with Hepatitis B Immune Globulin and Vaccine

  1992cited by this paper
• Gly145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus.

  1992cited by this paper
• Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide.

  1991cited by this paper
• Vaccine-induced escape mutant of hepatitis B virus.

  1990cited by this paper
• Host-independent evolution and a genetic classification of the hepadnavirus family based on nucleotide sequences.

  1989cited by this paper
• Two proteins with reverse transcriptase activities associated with hepatitis B virus-like particles

  1988cited by this paper
• Replication strategy of human hepatitis B virus

  1987cited by this paper
• Hepatitis B viral DNA-RNA hybrid molecules in particles from infected liver are converted to viral DNA molecules during an endogenous DNA polymerase reaction.

  1984cited by this paper
• Rapid evolution of RNA genomes.

  1982cited by this paper
• Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate.

  1982cited by this paper

• PNA Functionalized Gold Nanoparticles on TiO2 Nanotubes Biosensor for Electrochemical DNA Fragment Detection

  2025cites this paper
• HIV and hepatitis B co-infection - prevalence and clinical spectrum in a rural tertiary care centre of Northern India

  2017cites this paper
• Sequence analysis of sub-genotype D hepatitis B surface antigens isolated from Jeddah, Saudi Arabia

  2016cites this paper
• Identification of Novel D11 Hepatitis B Surface Antigen Subgenotype in Jeddah, Kingdom of Saudi Arabia

  2015cites this paper
• Detection of low copies of drug-resistant influenza viral gene by a single-tube reaction using peptide nucleic acid as both PCR clamp and sensor probe.

  2014cites this paper
• Characterization of HIV–HBV coinfection in a multinational HIV-infected cohort

  2013cites this paper
• Treatment of chronic hepatitis B with nucleos(t)ide analogues

  2012cites this paper
• An improved reverse dot hybridization for simple and rapid detection of adefovir dipivoxil-resistant hepatitis B virus.

  2012cites this paper
• PCR enrichment techniques to identify the diet of predators

  2012influential citation
• Mutant enrichment with 3'-modified oligonucleotides a practical PCR method for detecting trace mutant DNAs.

  2011cites this paper
• Sensitive Assay for Quantification of Hepatitis B Virus Mutants by Use of a Minor Groove Binder Probe and Peptide Nucleic Acids

  2010cites this paper
• HBV Drug Resistance Development, Testing, and Prevention

  2010cites this paper
• Infectivity and vaccination efficacy studies in animal models of HBV S and pol gene mutants.

  2010cites this paper
• HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice.

  2010cites this paper
• Development of PNA-based systems for food safety and molecular biology

  2010cites this paper
• Current treatment for chronic hepatitis B in Japan

  2009cites this paper
• Clinical application and research progress in hepatitis B virus quasispecies

  2008cites this paper
• Evaluation of dual priming oligonucleotide-based multiplex PCR for detection of HBV YMDD mutants

  2008cites this paper
• Technique for the Early Detection of Drug-Resistant HBV DNA during Antiviral Therapy

  2008cites this paper
• Hepatitis B virus S gene escape mutants

  2007cites this paper
• Single-tube reaction using peptide nucleic acid as both PCR clamp and sensor probe for the detection of rare mutations

  2007cites this paper
• Comparison of Mass Spectrometric Analysis and TRUGENE™ HBV Genotyping for Monitoring Lamivudine Resistance in Chronic Hepatitis B Patients

  2007cites this paper
• Mutations associated with lamivudine‐resistance in therapy‐naïve hepatitis B virus (HBV) infected patients with and without HIV co‐infection: Implications for antiretroviral therapy in HBV and HIV co‐infected South African patients

  2007influential citation
• Entecavir resistance is rare in nucleoside naïve patients with hepatitis B

  2006cites this paper
• Mutations affecting the replication capacity of the hepatitis B virus

  2006cites this paper
• How do naturally occurring YMDD‐motif mutants influence the clinical course of lamivudine‐naïve patients with chronic hepatitis B virus infection?

  2006cites this paper
• Electrochemical genosensor based on peptide nucleic acid-mediated PCR and asymmetric PCR techniques: Electrostatic interactions with a metal cation.

  2006cites this paper
• Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation.

  2005cites this paper
• A case of decompensated hepatitis B virus-related cirrhosis successfully treated with lamivudine and adefovir allowing repeated treatments for hepatocellular carcinomas

  2005cites this paper
• Failure to Detect Hepatitis B Virus in Vitreous by Polymerase Chain Reaction

  2005cites this paper
• G to A hypermutation of hepatitis B virus

  2005cites this paper
• Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter.

  2004cites this paper
• Rare Quasispecies in the YMDD Motif of Hepatitis B Virus Detected by Polymerase Chain Reaction with Peptide Nucleic Acid Clamping

  2003cites this paper